A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced ...
Post-bariatric hypoglycemia is a profoundly life-altering condition for patients. Having unpredictable hypoglycemia that people can't detect is really an unsafe situation. Researchers have developed a ...
Phase 3 registrational trial for ersodetug in patients with tumor hyperinsulinism (HI) expected to commence in 2025; real-world patient benefit demonstrated in Expanded Access Program REDWOOD CITY, ...
Researchers have shown that a targeted treatment they developed is effective at controlling blood sugar in patients with hyperinsulinism (HI), a genetic disease in which the pancreas produces too much ...
Disparities Between Provider Assessment and Documentation of Care Needs in the Care of Adolescent and Young Adult Patients With Sarcoma We used the Institute for Healthcare Improvement (IHI) Model for ...
REDWOOD CITY, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (RZLT) (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by ...
New research has taken an important step towards the goal for a treatment for the common diabetes complication hypoglycemia, or low blood sugar. In all forms of diabetes, blood sugars become too high ...
Individualized nutrition therapy is recommended. Monitoring carbohydrate intake is critical to achieving glycemic control. Comprehensive nutrition education is recommended at diagnosis with annual ...
Hypoglycemia is a condition marked by an abnormally low level of blood sugar (glucose), your body’s main energy source. It is commonly associated with the treatment of diabetes, although people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback